Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Blood lipids have been associated with the development of a range of cancers, including breast, lung and colorectal cancer. For endometrial cancer, observational studies have reported inconsistent associations between blood lipids and cancer risk. To reduce biases from unmeasured confounding, we performed a bidirectional, two-sample Mendelian randomization analysis to investigate the relationship between levels of three blood lipids (low-density lipoprotein [LDL] and high-density lipoprotein [HDL] cholesterol, and triglycerides) and endometrial cancer risk. Genetic variants associated with each of these blood lipid levels (P 

Original publication

DOI

10.1002/ijc.33206

Type

Journal article

Journal

Int J Cancer

Publication Date

15/01/2021

Volume

148

Pages

307 - 319

Keywords

HDL cholesterol, LDL cholesterol, Mendelian randomization, endometrial cancer risk, triglycerides, Case-Control Studies, Cholesterol, HDL, Cholesterol, LDL, Endometrial Neoplasms, Female, Genome-Wide Association Study, Humans, Mendelian Randomization Analysis, Risk, Triglycerides